Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway

Parkinson’s disease (PD) is an age-related, progressive neurodegenerative disease characterized by the gradual and massive loss of dopaminergic neurons in the substantia nigra pars compacta (SNc). We have recently reported that artemisinin, an FDA-approved first-line antimalarial drug, possesses a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qin, Li, Shuai, Fang, Jiankang, Yang, Chao, Zhao, Xia, Wang, Qing, Zhou, Wenshu, Zheng, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385954/
https://www.ncbi.nlm.nih.gov/pubmed/37513399
http://dx.doi.org/10.3390/molecules28145527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385954/
https://www.ncbi.nlm.nih.gov/pubmed/37513399
http://dx.doi.org/10.3390/molecules28145527

Ejemplares similares